He was scheduled to have an MRI next week to further evaluate the lesion and he was very nervous about that.
Inital vitals were 99.0 82 136/76 18 95%RA.
Past Medical History: -- HTN -- CAD s/p RCA stent in [**8-/2164**] -- s/p closed fract tib/fib -- SVT (AVRT v. AVNRT) -- Chronic EtOH abuse (no h/o seizures; s/p detox 3 years ago, referred to [**Hospital1 1680**] house partial hospitalization program [**5-5**]) -- Depression/anxiety ([**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 66064**] [**Numeric Identifier 100681**] @ [**Hospital1 1680**] JP; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 12528**] [**Telephone/Fax (1) 5260**]) -- Neurofibromatosis - dx on last admission  Social History: Unemployed, living alone in [**Location (un) **] MA.
Physical Exam: T 97.2 BP 138/117 HR 121 RR19 O2 95%RA General: comfortable, lying in bed, appears slightly dissheveled HEENT: PERRL, poor dentition Neck: soft, NT/ND Cardiac: tachycardic Pulmonary: CTA B/L Abdomen: soft non-tender, non-distended, + bowel sounds Extremities: no edema, mild tremor of the hands Skin: numerous small subcutaneous nodules  Pertinent Results: None  Brief Hospital Course: The patient is a 58M h/o SVT, CAD s/p stent, chronic EtOH abuse, depression and anxiety presenting with EtOH intoxication.
His valium was quickly tapered to [**Hospital1 **] and then daily.
He was scheduled for an MRI [**8-30**] (day of discharge) on the [**Hospital Ward Name **] as part of a study protocol.
Followup Instructions: Please follow-up with the following appointments: Provider: [**Name10 (NameIs) 6131**] [**Name11 (NameIs) **], MD Phone:[**Telephone/Fax (1) 253**] Date/Time:[**2168-8-31**] 1:30 Provider: [**First Name8 (NamePattern2) **] [**Name11 (NameIs) 815**], MD Phone:[**Telephone/Fax (1) 250**] Date/Time:[**2168-9-1**] 2:30
